Del Tedesco E - Search Results

1

Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience.

Del Tedesco E, Roblin X, Laharie D, Peyrin Biroulet L. Del Tedesco E, et al. Inflamm Bowel Dis. 2011 Aug;17(8):1824. doi: 10.1002/ibd.21602. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21744437 No abstract available.

2

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

Roblin X, Vérot C, Paul S, Duru G, Williet N, Boschetti G, Del Tedesco E, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B. Roblin X, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2018 Aug 16;24(9):2078-2085. doi: 10.1093/ibd/izy111. Inflamm Bowel Dis. 2018. PMID: 29718216

3

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.

Danion P, Buisson A, Roblin X, Mathieu N, Charlois AL, Borgerding JN, Williet N, Del Tedesco E, Flourié B, Nancey S, Boschetti G. Danion P, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2018 Apr 23;24(5):943-952. doi: 10.1093/ibd/izx073. Inflamm Bowel Dis. 2018. PMID: 29506217

4

Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.

Paul S, Moreau AC, Del Tedesco E, Rinaudo M, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X. Paul S, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2014 Jul;20(7):1288-95. doi: 10.1097/MIB.0000000000000037. Inflamm Bowel Dis. 2014. PMID: 24831559 Review.

5

Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis.

Moreau AC, Paul S, Del Tedesco E, Rinaudo-Gaujous M, Boukhadra N, Genin C, Peyrin-Biroulet L, Roblin X. Moreau AC, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2014 Mar;20(3):464-71. doi: 10.1097/01.MIB.0000439068.71126.00. Inflamm Bowel Dis. 2014. PMID: 24418904

6

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.

Roblin X, Boschetti G, Duru G, Williet N, Deltedesco E, Phelip JM, Peyrin-Biroulet L, Nancey S, Flourié B, Paul S. Roblin X, et al. Inflamm Bowel Dis. 2017 Nov;23(11):2048-2053. doi: 10.1097/MIB.0000000000001223. Inflamm Bowel Dis. 2017. PMID: 28945636

7

Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus!

Roblin X, Del Tedesco E. Roblin X, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2013 Apr;19(5):E67-8. doi: 10.1097/MIB.0b013e318281013f. Inflamm Bowel Dis. 2013. PMID: 23314247 No abstract available.

8

Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study.

Paul S, Williet N, Di Bernado T, Berger AE, Boschetti G, Filippi J, Del Tedesco E, Nancey S, Flourie B, Roblin X. Paul S, et al. Among authors: del tedesco e. J Crohns Colitis. 2018 Aug 29;12(9):1089-1096. doi: 10.1093/ecco-jcc/jjy077. J Crohns Colitis. 2018. PMID: 29860366

9

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.

Roblin X, Duru G, Williet N, Del Tedesco E, Cuilleron M, Jarlot C, Phelip JM, Boschetti G, Flourié B, Nancey S, Peyrin-Biroulet L, Paul S. Roblin X, et al. Among authors: del tedesco e. Inflamm Bowel Dis. 2017 Jan;23(1):126-132. doi: 10.1097/MIB.0000000000000986. Inflamm Bowel Dis. 2017. PMID: 28002129

10

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months.

Williet N, Boschetti G, Fovet M, Di Bernado T, Claudez P, Del Tedesco E, Jarlot C, Rinaldi L, Berger A, Phelip JM, Flourie B, Nancey S, Paul S, Roblin X. Williet N, et al. Among authors: del tedesco e. Clin Gastroenterol Hepatol. 2017 Nov;15(11):1750-1757.e3. doi: 10.1016/j.cgh.2016.11.023. Epub 2016 Nov 24. Clin Gastroenterol Hepatol. 2017. PMID: 27890854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results